INTRODUCTION
Hypothyroidism progressively increasing globally in spite of W.H.O caution and measures to restrict Iodine deficiency and estimates burden of 42 millions population in India which is considered due to increasing dietary non nutrients and changed life style. Dietary non nutrients alter iodination of tyrosine and C cells of thyroid suppressing calcium metabolism resulting in deficiency of ionic form of calcium, accumulation of free radicals, thus presents with manifestations of thyroid hypofunction and hypocalcaemia.
Thus patients of hypothyroidism, L-thyroxine supplementation is a prime need and its administration schedule poses varied clinical outcome, as in cases though TSH level gets declined but clinical presentation become worse thus patients taking Levothyroxine supplementation been evaluated to adjudge the clinical outcome and quality of life with fixed time early morning dose and varied time schedule . [6] [7] Alteration in thyroid function is common among female and hypothyroidism a common presentation among women these days. Hypothyroidism suppresses BMR through its effect on decline in gonadal hormone specially estrogenic and testosterone which causes sub cutaneous accumulation of mucin and retention of water and electrolyte and presents with -myxoedema, asthenia, leg cramps, exertional dyspnoea constipation etc, in addition also suppress sexual function and menses. [8] [9] The most common parameters of ascertaining is assessment of serum thyroxin(T4) and thyroid stimulating hormone (TSH)and therapeutic supplement used is Levothyroxine but unawareness or incomplete education regarding schedule of levothyroxine supplementation, patients consume this supplements with variability [10] [11] [12] [13] [14] [15] [16] [17] i.e.- 
Methods
Selected patients irrespective of their disease status were interrogated for their disease duration, type of therapeutic consumption, their clinical effect, present status, history of consumption of Levothyroxine suppliments, their dose. After clinical examination patients were assessed for their thyroid profile, body weight, blood pressure, blood sugar, hepatic, hematological and renal profile, lipid profile, serum calcium, vitamin D3 and ECG. In patients of hypertension, history of convulsion or unconsciousness.
Based on the clinical presentation and thyroid profile patients were classified as 18-21 - For ease of study patients were categorised in two groups and administered i.e.- Among selected patients 66.2% patients were with haemoglobin >10gm %, 5% were with SGOT and SGPT >30 IU, 99.9% posses normal renal profile though 2.4% shows presence of albumin, 0.2% presence of RBC and 64.2% presence of calcium oxalate sand in urine, 99.6% were with normal serum cholesterol, 37.6% with low Vitamin D3 and 39% with low serum calcium.
Study of Therapeutic Response on Variable Levothyroxine Supplementation in Hypothyroi dism
Out of all patients taking L-thyroxin supplementation at early morning at fixed time (group A) were 467 and 533 were taking L-thyroxin supplementation at unscheduled manner daily (group B). Group A constitutes no male patients.
Patients of group A shows sustained and progressive decline in TSH level in all while patients of group B shows variable and mild decline in TSH level.
97.6% patients of group A had marked relief in clinical presentation while only 63.4% of group B, 99.6% of group A patients had progressive decline in body weight and attended Ideal body weight without any discomfort while only 21.2% of group B had declined in body weight but non attended ideal body weight for the age and height and 35.8% patients of group B had abnormal muscle mass growth.
87.6% patients of group A had blood pressure bioregulation while 62.7% patients of group B remained with low blood pressure. 81.8% of group A had relief of constipation while 20.4 of group B, menses and libido marked improved in 84.8% and 92.8% respectively of group A contrary to 5.2% and 27.4% respectively of group B.
Conclusively 97.6% of group A achieved grade I therapeutic outcome as against 7%of group B (T-)
DISCUSSION
Thyroid secretes hormone to bio regulate body metabolism and its under activity is termed as hypothyroidism i.e.-persons suffering with hypothyroidism presents with manifestation of slow metabolism. Approximately one in 50 women and 1 in 1000 men suffers with hypothyroidism in their life and TSH (Thyroid stimulating Hormone, secreted by Pituitary gland) level is a most sensitive index, as elevated TSH level always suggest under activity of thyroid.
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Though various dose schedule been clinically evaluated but early morning fixed time consumption through out life remain worth as it ensure sustained and progressive decline in TSH level, marked relief of clinical presentation, decline in body weight, normotensive state and grade I clinical out come with improved quality of life in 97% patient while other schedules fail to ensure even symptomatic relief though causes decline in TSH level. This clinical supremacy can be explained asEarly morning fixed time consumption of Laevo thyroxin acted by oral saliva and salivary amylase effect gets pronounced while consumption after oral ingestion or water intake oral saliva gets washed off or diluted thus administered L thyroxin fails to potentiate salivary amylase and restricted conversion of T4 to T3, hence early morning consumption not only causes decline in TSH but also ensure clinical improvement [29] [30] [31] .
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